Complete remission of multiple myeloma associated scleredema after bortezomib-based treatment

SZTURZ, Petr, Zdeněk ADAM, Vladimír VAŠKŮ, Josef FEIT, Marta KREJČÍ, Luděk POUR, Roman HÁJEK and Jiří MAYER. Complete remission of multiple myeloma associated scleredema after bortezomib-based treatment. LEUKEMIA & LYMPHOMA. LONDON: INFORMA HEALTHCARE, 2013, vol. 54, No 6, p. 1324-1326. ISSN 1042-8194. Available from: https://dx.doi.org/10.3109/10428194.2012.738816.

Basic information

• Original name: Complete remission of multiple myeloma associated scleredema after bortezomib-based treatment
• Authors: SZTURZ, Petr (203 Czech Republic, guarantor, belonging to the institution), Zdeněk ADAM (203 Czech Republic), Vladimír VAŠKŮ (203 Czech Republic, belonging to the institution), Josef FEIT (203 Czech Republic, belonging to the institution), Marta KREJČÍ (203 Czech Republic, belonging to the institution), Luděk POUR (203 Czech Republic, belonging to the institution), Roman HÁJEK (203 Czech Republic, belonging to the institution) and Jiří MAYER (203 Czech Republic, belonging to the institution).
• Edition: LEUKEMIA & LYMPHOMA, LONDON, INFORMA HEALTHCARE, 2013, 1042-8194.

Other information

• Original language: English
• Type of outcome: Article in a journal
• Field of Study: 30200 3.2 Clinical medicine
• Country of publisher: United Kingdom of Great Britain and Northern Ireland
• Confidentiality degree: is not subject to a state or trade secret
• Impact factor: Impact factor: 2.605
• RIV identification code: RIV/00216224:14110/13:00065629
• Organization unit: Faculty of Medicine
• Doi: http://dx.doi.org/10.3109/10428194.2012.738816
• UT WoS: 000318806400035
• Keywords in English: SCLEROMYXEDEMA; DEXAMETHASONE; ADULTORUM; BUSCHKE; THALIDOMIDE; DISORDERS; PATIENT; DISEASE
• Tags: 18 06 2013
• Tags: International impact, Reviewed

Abstract

Scleredema is a rare scleroderma-like fi bromucinosis characterized by progressive thickening of the skin caused by excessive collagen and mucin depositions in the dermis. Various treatment regimens have been proposed, however with inconsistent outcomes. Herein we are the fi rst to report a complete dermatological and hematological remission in a patient with multiple myeloma associated scleredema after bortezomib-based chemotherapy.

Links

• GAP304/10/1395, research and development project: Name: Analýza klonálních progenitorů plazmatických buněk u monoklonálních gamapatií

Investor: Czech Science Foundation

• MUNI/A/0784/2011, interní kód MU: Name: Nové diagnostické a klinické přístupy v onkologii (Acronym: NoDiKliPO)

Investor: Masaryk University, Category A

• NT13190, research and development project: Name: Molekulární charakteristika centrozomálních abnormalit a jejich prognostický význam pro pacienty s mnohočetným myelomem

Investor: Ministry of Health of the CR

• NT13492, research and development project: Name: Úloha genetických abnormalit ve vývoji a progresi prekancerózy monoklonální gamapatie nejasného významu